Pfizer is going to build a cutting-edge sterile injectable facility in Michigan.
(Source: Pfizer)
New York/USA — Known as Modular Aseptic Processing (MAP), the new, multi-story, 37,000-m2-production facility will also create an estimated 450 new jobs over the next several years. This expands the company’s presence in Portage, located in Kalamazoo County, where the company now employs more than 2,200 people at one of its largest plants.
Ian Read, Chairman and Chief Executive Officer, said that this investment was part of the company's overall plan announced in January to invest approximately $ 5 billion in US-based capital projects as a result of the enactment of the Tax Cuts and Jobs Act. During the next six years, he expects to invest approximately $ 1.1 billion in Kalamazoo County — which was in addition to the $ 1 billion the company invested in the site over the past decade.
Ron Perry, Site Leader for the Portage plant, said the new sterile injectable facility will strengthen the site’s role in Pfizer’s global network. Sterile drug product manufacturing was incredibly complex and this contemporary facility would combine cutting-edge technology and a highly talented workforce to assure the company remained a trusted and reliable supplier of these therapies to patients, he added.
MAP will incorporate technically advanced aseptic manufacturing equipment, systems and design, including multiple, self-contained modular manufacturing lines. This allows the manufacturing line in each module to be entirely separate from all other manufacturing lines. Groundbreaking is planned for spring 2019, with construction expected to be completed in 2021. After the facility is validated by regulatory agencies, production should begin in 2024.
Unfold for details of your consent
Stand vom 23.03.2021
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.
:quality(80)/p7i.vogel.de/wcms/16/af/16af797a8a1f8bb82362dfa476acb996/0104964405.jpeg "0104964405")
:quality(80)/p7i.vogel.de/wcms/c0/34/c034428f6f7de33dbc90e8b1fdc7fb21/0104949732.jpeg "0104949732")
:quality(80)/p7i.vogel.de/wcms/d0/ad/d0ad8816b1cb1e574219ccc37fd87bb6/0104947863.jpeg "0104947863")
:quality(80)/p7i.vogel.de/wcms/28/c4/28c48eeed20dee57a6b89ff1ef3a21e5/0104921072.jpeg "0104921072")
:quality(80)/p7i.vogel.de/wcms/d9/4b/d94b9122c3c0cb11915ca1e116bea997/0104986115.jpeg "0104986115")
![Dr. E. Poonguzhali has successfully transferred commercially available starting materials to medicinally important 2-acylbenzo[b]thiophenes in the presence of copper acetate & tetrabutylammonium chloride catalytic system.](https://cdn1.vogel.de/ZK7wqjVy7Ps1OSwUs5tXgrNZGEE=/288x162/smart/filters:format(jpg):quality(80)/images.vogel.de/vogelonline/bdb/1964500/1964559/original.jpg "Dr. E. Poonguzhali has successfully transferred commercially available starting materials to medicinally important 2-acylbenzo[b]thiophenes in the presence of copper acetate & tetrabutylammonium chloride catalytic system.")
:quality(80)/images.vogel.de/vogelonline/bdb/1963700/1963740/original.jpg "The high resolution, modern TFT touch display has a multi-lingual user interface and shows all important information at a glance.")
:quality(80)/images.vogel.de/vogelonline/bdb/1963400/1963417/original.jpg "The 700kHz, 260-element histotripsy ultrasound array transducer used in Prof. Xu’s lab.")
:quality(80)/images.vogel.de/vogelonline/bdb/1963800/1963885/original.jpg "Anna-Lisa Paul, left, and Rob Ferl, working with lunar soils in their lab.")
:quality(80)/images.vogel.de/vogelonline/bdb/1962400/1962494/original.jpg "The operating room produces 70 percent of hospitals' greenhouse gas emissions, but two surgeons-in-training have come up with solutions to reduce that number.")
:quality(80)/images.vogel.de/vogelonline/bdb/1960700/1960778/original.jpg "This plant is modeling the latest wearable sensor (right) to monitor water loss from leaves with a smartphone app (left).")
:quality(80)/images.vogel.de/vogelonline/bdb/1958800/1958848/original.jpg "The user-friendly unit, which weighs less than ten kilograms and does not require the use of filters, can be powered by a small, portable solar panel.")
:quality(80)/p7i.vogel.de/wcms/0d/3b/0d3b418adb4c7af71022c52878dd8fdf/0104800005.jpeg "0104800005")
:quality(80)/images.vogel.de/vogelonline/bdb/1963700/1963732/original.jpg)
:quality(80)/images.vogel.de/vogelonline/bdb/1963500/1963506/original.jpg "Healthy adults eating a diverse diet with at least eight to ten grams of soluble fiber a day have fewer antibiotic-resistant microbes in their guts. Soluble fiber is found in foods such as grains, beans, lentils, nuts, and some fruits and vegetables.")
:quality(80)/images.vogel.de/vogelonline/bdb/1963400/1963459/original.jpg "Thermo Scientific Dionex Ionpac CS21-Fast-4m ion exchange column.")
:quality(80)/p7i.vogel.de/wcms/29/a8/29a87518fdfa5741b9cf4429a448729f/0104917902.jpeg "0104917902")
:quality(80)/p7i.vogel.de/wcms/93/1b/931ba9a54f6fff41d2cdd7cf74a1e174/0104884529.jpeg "0104884529")
:quality(80)/p7i.vogel.de/wcms/b7/3c/b73c41e85851adc1e2be52f7eefa194f/0104868646.jpeg "0104868646")
:quality(80)/p7i.vogel.de/wcms/77/2f/772fff5fcac0b56d38440fa8d30b6b07/0104868618.jpeg "0104868618")
:quality(80)/images.vogel.de/vogelonline/bdb/1710600/1710675/original.jpg "Discover how to set yourself up for success when performing balance-based density determination of solids such as jewelry and precious metals.")
:quality(80)/images.vogel.de/vogelonline/bdb/1682500/1682579/original.jpg "The new XPR Analytical balance redesigned to meet the needs of laboratory technicians of working fast and lean.")
:quality(80)/images.vogel.de/vogelonline/bdb/1677000/1677080/original.jpg "Enhance your weighing accuracy, comfort and productivity with the redesigned XPR Analytical balance.")
:quality(80)/images.vogel.de/vogelonline/bdb/1832600/1832670/original.jpg "BD will build a new € 165 million manufacturing facility to support the ongoing growth of pre-filled drug delivery products.")
:quality(80)/images.vogel.de/vogelonline/bdb/1777100/1777135/original.jpg "The Emergency Use Authorisation in the U.K. will mark the first time citizens outside of the trials will have the opportunity to be immunised against Covid-19.")